37 CHAPTER 3 Minimally interrupted novel oral anticoagulant versus uninterrupted vitamin K antagonist during atrial fibrillation ablation John de Heide; Christiaan J. Vroegh; Rohit E. Bhagwandien; Sip A. Wijchers; Tamas Szili-Torok; Felix Zijlstra; Mattie J. Lenzen & S.C. Yap Department of Cardiology, Erasmus Medical Center, P.O. Box 2040, 3000 CA Rotterdam, the Netherlands Journal of Interventional Cardiac Electrophysiology, Aug 2018, 53, p. 341–346, https://doi.org/10.1007/s10840-018-0417-0
RkJQdWJsaXNoZXIy MTk4NDMw